Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Catalina Pérez-Olives
Observed name:
Pérez Olives, Catalina
Institution:
Instituto de Investigación Biomédica de Lleida
Observed institutions:
Instituto de Salud Carlos III,
Biomedical Research Networking Center on Neurodegenerative Diseases,
Instituto de Investigación Biomédica de Lleida,
Universitat de Barcelona
ORCID:
0000-0003-4088-267X
Observed ORCID:
0000-0003-4088-267X
OpenAlex ID:
A5024915516
Recent Advances in the Potential of Cannabinoids for Neuroprotection in Alzheimer’s, Parkinson’s, and Huntington’s Diseases
2020
·
Catalina Pérez-Olives
, Rafael Rivas-Santisteban
, et al.
·
Advances in experimental medicine and biology
·
54
Pharmacological potential of varinic-, minor-, and acidic phytocannabinoids
2020
·
Rafael Franco
, Rafael Rivas-Santisteban
, et al.
·
Pharmacological Research
·
44
Membrane Heteroreceptor Complexes as Second-Order Protein Modulators: A Novel Integrative Mechanism through Allosteric Receptor–Receptor Interactions
2024
·
Marina Mirchandani-Duque
, Malak Choucri
, et al.
·
Membranes
·
16
PDF
Expression of the Adenosine A2A-A3 Receptor Heteromer in Different Brain Regions and Marked Upregulation in the Microglia of the Transgenic APPSw,Ind Alzheimer’s Disease Model
2022
·
Alejandro Lillo
, Iu Raïch
, et al.
·
Biomedicines
·
13
PDF
Cannabinoid CB1 Receptor Activation Mitigates N-Methyl- d -aspartate Receptor-Mediated Neurotoxicity
2025
·
Gemma Navarro
, Iu Raïch
, et al.
·
ACS Pharmacology & Translational Science
·
3
PDF
N-methyl-D-aspartate receptor inhibition protects against obesity-induced kidney disease
2026
·
Àuria Eritja
, Catalina Pérez-Olives
, et al.
·
Nephrology Dialysis Transplantation
Adenosine A2A Receptor-Containing Heteromers and Neuroprotection
2023
·
Rafael Franco
, Rafael Rivas-Santisteban
, et al.
·
Springer eBooks
Show more works
View as search
Works count:
8
Citation count:
130
H-index:
4
I10-index:
4
Year
Topic
Type